Should You Invest in Well Health Stock Right Now?

WELL Health (TSX:WELL) stock climbed to all-time highs and now trades at 52-week lows. So, is the company a buy?

| More on:
telehealth stocks

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

WELL Health Technologies (TSX:WELL) is a story that shouldn’t be missed. The once-great healthcare tech stock soared into prominence during the pandemic. We all saw the rise of virtual healthcare companies such as this one, where we couldn’t really go wrong.

Yet apparently, we could, with companies including WELL Health stock dropping into oblivion after soaring to all-time highs. Now that it’s near 52-week lows, investors are likely wondering if it is a good time to buy WELL Health stock.

The bull case

WELL Health stock certainly has a lot going for it when you look at its earnings reports. The company continues to post record after record in its earnings and doesn’t show any signs of slowing down. Plus, it’s been a merger and acquisition powerhouse, buying up telehealth companies across North America.

WELL Health stock is in fact now the largest outpatient clinic in Canada and looks like it’s eyeing the United States next. This looks potentially achievable if earnings are any indication. The company’s recent earnings report included record quarterly revenue at $145.8 million, a 47% year-over-year increase, and mainly from organic growth.

Furthermore, it saw its virtual services unit grow by 75% compared to last year and increased its guidance to this year as well. It now expects to exceed $565 million, up from $550 million the quarter before. This was yet another consecutive quarter where the company increased guidance.

The bear view

There is, of course, another side to this story. We’ve seen in many instances the plague of the companies that grow too fast, too soon. They expand without the balance sheet to support them. Then everything comes crashing down. And there is some merit to this in the case of WELL Health stock, though not completely.

Many worried that after the end of pandemic restrictions, patients would return to in-person consultants when it came to their healthcare. And that has happened, it’s true, but certainly not as much as investors may have feared. Still, this could be a slow process that many see could eventually come to fruition in the case of WELL Health stock.

Plus, it’s a tech stock, and unless it continues to innovate and innovate some more, investors may feel there is only so much the company can do. In this case, there is certainly a limit to how high WELL Health stock can climb.

Bottom line

In my view, I look to what analysts believe the future has in store for WELL Health stock. And in this case, the future is bright. Although analysts did, in fact, downgrade the price targets given the economic downturn, overall, they believed the stock to be a superior choice.

After solid third-quarter results and earnings before interest, taxes, depreciation, and amortization that beat out consensus estimates, analysts believe strong growth with happen once more. In fact, shares could double or even triple in the next year, if analysts are to be believed.

The biggest factor to me, however, is the company’s debts. Here, that’s where WELL Health stock looks solid. As of writing it would take just 46.35% of equity to pay off all its debts. So, with growth in the future in every respect, and a solid balance sheet with debt under control, I believe WELL Health stock to be a strong buy today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in WELL Health Technologies Corp. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Tech Stocks

A worker uses a double monitor computer screen in an office.
Tech Stocks

Why Shopify Stock Sold Off Last Week

Shopify (TSX:SHOP) sold off heavily last week. A bad earnings release may have been the culprit.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Phenomenal Growth Stocks Down 30-60% That Could Rally in the Next Bull Market

Is it time to buy growth stocks? The worst of the interest rate hike and inflation is over, and now…

Read more »

stock market
Tech Stocks

2 Best Tech Stocks to Buy Before the Next Bull Market

Tech stocks such as Roku and Nuvei can help long-term investors generate outsized gains in 2023 and beyond.

Read more »

Wireless technology
Tech Stocks

Tucows Stock Trades Near its 6-Year Low: Is it a Buy?  

Tucows stock fell 63% in the tech stock sell-off and has failed to show any recovery. Is this domain and…

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Converge Stock a Buy?

A relatively new tech stock could soar higher with the pause in rate hikes, although a resumption of the cycle…

Read more »

online shopping
Tech Stocks

Up by 25%: Is Shopify Stock Finally a Buy in 2023?

The strong rebound in the TSX’s top tech stock remains uncertain. Investors will have to wait before it delivers stellar…

Read more »

Businessman holding AI cloud
Tech Stocks

2 TSX Tech Stocks Innovating Hard in AI

Shopify (TSX:SHOP) stock and another intriguing Canadian gem make good use of AI technologies.

Read more »

worry concern
Tech Stocks

Shopify Stock: Incredible Bargain or Deceptive Trap?

Shopify has quickly shifted from a market darling to something else. Is it a safe buy or risqué bet?

Read more »